Close

Drug Labeling: BIO Comments on CBE-0 Proposed Rule

<p>
The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA or Agency) for the opportunity to submit comments on the &quot;Proposed Rule: Supplemental Applications Proposing Labelling Changes for Approved Drugs and Biological Products.&quot;</p>

BIO Comments on CBE-0 Proposed Rule